Menu
Menu
| Product | Therapeutic Area | Profile | Estimated Launch Date |
|---|---|---|---|
| KSN-SP-001 | Cardiovascular | Oral liquid product that enhances ease of administration, patient convenience, and dosing compliance for chronic treatment | Q2 2024 |
| KSN-SP-002 | Anti-Infective | Oral liquid product that provides taste masking and dosage convenience | Q2 2023 |
